Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HWG5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 95 | 99 | PF00656 | 0.481 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.367 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.469 |
CLV_PCSK_FUR_1 | 178 | 182 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.437 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.463 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.437 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.496 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.618 |
CLV_PCSK_SKI1_1 | 181 | 185 | PF00082 | 0.451 |
DOC_MAPK_gen_1 | 128 | 136 | PF00069 | 0.445 |
DOC_MAPK_MEF2A_6 | 128 | 136 | PF00069 | 0.563 |
DOC_USP7_UBL2_3 | 180 | 184 | PF12436 | 0.485 |
DOC_USP7_UBL2_3 | 21 | 25 | PF12436 | 0.609 |
LIG_14-3-3_CanoR_1 | 103 | 111 | PF00244 | 0.413 |
LIG_14-3-3_CanoR_1 | 28 | 32 | PF00244 | 0.540 |
LIG_14-3-3_CanoR_1 | 63 | 69 | PF00244 | 0.412 |
LIG_14-3-3_CanoR_1 | 92 | 100 | PF00244 | 0.492 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.596 |
LIG_BRCT_BRCA1_1 | 178 | 182 | PF00533 | 0.553 |
LIG_BRCT_BRCA1_2 | 178 | 184 | PF00533 | 0.555 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.619 |
LIG_Integrin_RGD_1 | 161 | 163 | PF01839 | 0.445 |
LIG_LIR_Gen_1 | 179 | 189 | PF02991 | 0.521 |
LIG_LIR_Nem_3 | 171 | 176 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 77 | 83 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 86 | 91 | PF02991 | 0.356 |
LIG_LYPXL_yS_3 | 88 | 91 | PF13949 | 0.361 |
LIG_REV1ctd_RIR_1 | 98 | 107 | PF16727 | 0.471 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.631 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.305 |
LIG_TRAF2_1 | 50 | 53 | PF00917 | 0.536 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.336 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.645 |
MOD_GlcNHglycan | 32 | 36 | PF01048 | 0.552 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.560 |
MOD_N-GLC_2 | 138 | 140 | PF02516 | 0.386 |
MOD_PKA_2 | 109 | 115 | PF00069 | 0.313 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.540 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.508 |
MOD_Plk_1 | 189 | 195 | PF00069 | 0.506 |
MOD_SUMO_rev_2 | 160 | 166 | PF00179 | 0.448 |
MOD_SUMO_rev_2 | 190 | 197 | PF00179 | 0.588 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.351 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.362 |
TRG_ER_diArg_1 | 56 | 58 | PF00400 | 0.504 |
TRG_ER_diArg_1 | 91 | 93 | PF00400 | 0.446 |
TRG_ER_diLys_1 | 196 | 201 | PF00400 | 0.521 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3B2 | Leptomonas seymouri | 83% | 100% |
A0A0S4IW52 | Bodo saltans | 53% | 100% |
A0A1X0NTV3 | Trypanosomatidae | 68% | 100% |
A0A3R7NUR7 | Trypanosoma rangeli | 65% | 100% |
A0A3S7WTG2 | Leishmania donovani | 100% | 100% |
A4H838 | Leishmania braziliensis | 90% | 100% |
C9ZXY0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 96% |
E9AQ66 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4QFB7 | Leishmania major | 97% | 100% |
V5BPN5 | Trypanosoma cruzi | 64% | 100% |